Collegium Appoints Vikram Karnani as Chief Executive Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Collegium Pharmaceutical (COLL) PT Lowered to $40 at Jefferies
November 11, 2024 3:55 PM ESTJefferies analyst Glen Santangelo lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $40.00 (from $44.00) while maintaining a Buy rating.
The analyst comments "Model update post 3Q results. Overall, we remain encouraged by momentum in the underlying pain portfolio, coupled with new LT... More

